The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

SOHO 2019 | What is in the pipeline for the treatment of T-cell lymphoma?

Sep 18, 2019

During SOHO 2019, Houston, US, the Lymphoma Hub asked Dr Owen A. O’Connor from Columbia University, New York, US, about treatments in the pipeline for T-cell lymphoma. He gives an update on the recent clinical developments for patients with relapsed or refractory diseases. He also describes treatment paradigms incorporating combinations of drugs with novel backbones, which hopefully in the future will replace CHOP-based therapies.

What is in the pipeline for the treatment of T-cell lymphoma?